These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9844107)
1. Hydroxyapatite induces autolytic degradation and inactivation of matrix metalloproteinase-1 and -3. Kremer EA; Chen Y; Suzuki K; Nagase H; Gorski JP J Bone Miner Res; 1998 Dec; 13(12):1890-902. PubMed ID: 9844107 [TBL] [Abstract][Full Text] [Related]
2. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Yasuda T; Poole AR Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586 [TBL] [Abstract][Full Text] [Related]
3. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883 [TBL] [Abstract][Full Text] [Related]
4. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression. Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284 [TBL] [Abstract][Full Text] [Related]
5. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Bini A; Itoh Y; Kudryk BJ; Nagase H Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941 [TBL] [Abstract][Full Text] [Related]
6. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033 [TBL] [Abstract][Full Text] [Related]
7. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126 [TBL] [Abstract][Full Text] [Related]
8. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081 [TBL] [Abstract][Full Text] [Related]
9. Type I collagen stabilization of matrix metalloproteinase-2. Ellerbroek SM; Wu YI; Stack MS Arch Biochem Biophys; 2001 Jun; 390(1):51-6. PubMed ID: 11368514 [TBL] [Abstract][Full Text] [Related]
10. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study]. Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Hui A; Min WX; Tang J; Cruz TF Arthritis Rheum; 1998 May; 41(5):869-76. PubMed ID: 9588740 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid. Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728 [TBL] [Abstract][Full Text] [Related]
15. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708 [TBL] [Abstract][Full Text] [Related]
16. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts. Ninomiya JT; Struve JA; Stelloh CT; Toth JM; Crosby KE J Orthop Res; 2001 Jul; 19(4):621-8. PubMed ID: 11518271 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871 [TBL] [Abstract][Full Text] [Related]
18. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931 [TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors. Bawadi HA; Antunes TM; Shih F; Losso JN J Agric Food Chem; 2004 Jul; 52(15):4730-6. PubMed ID: 15264907 [TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Tao Y; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]